tirzepatide and hypertension Patients who took the anti-obesity drug for almost two years lost 25 percent of their body weight maintained improvements in metabolic and cardiovascular health, according to a new phase 3 Tirzepatide Blood Pressure Reduction: Clinical

Researchers examining inflammatory disease models, gut epithelial biology, or mucosal immunity alongside tissue repair endpoints choose KLOW

For those incorporating Semaglutide into their weight loss plan, B-12 can complement this treatment by addressing potential fatigue or weakness associated with weight loss efforts

6,11 Areas of interest include oxidative stress, chronic low-grade inflammation, mitochondrial dysfunction, and central sensitization mechanisms that contribute to neuropathic pain

Presented for research literature review only Hao X et al

For people using insulin or other glucose-lowering medicines, eating less may change the risk of low blood sugar

More from Deciphering Digital Biweekly briefings on whats being said online, and what it means for the people responsible for reputation and risk